These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8917410)

  • 21. Active Ingredients of Hange-shashin-to, Baicalelin and 6-Gingerol, Inhibit 5-Fluorouracil-Induced Upregulation of CXCL1 in the Colon to Attenuate Diarrhea Development.
    Sakai H; Tabata S; Kimura M; Yabe S; Isa Y; Kai Y; Sato F; Yumoto T; Miyano K; Narita M; Uezono Y
    Biol Pharm Bull; 2017; 40(12):2134-2139. PubMed ID: 29199237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curcumin Inhibits 5-Fluorouracil-induced Up-regulation of CXCL1 and CXCL2 of the Colon Associated with Attenuation of Diarrhoea Development.
    Sakai H; Kai Y; Oguchi A; Kimura M; Tabata S; Yaegashi M; Saito T; Sato K; Sato F; Yumoto T; Narita M
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):540-547. PubMed ID: 27194111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized phase II trial of 5-fluorouracil, with or without human interferon-beta, for advanced colorectal cancer.
    Villar-Grimalt A; Candel MT; Massuti B; Lizón J; Sánchez B; Frau A; Gorostidi B; Goedkoop R
    Br J Cancer; 1999 May; 80(5-6):786-91. PubMed ID: 10360656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of 5-fluorouracil on the drug-metabolizing enzymes of the small intestine and the consequent drug interaction with nifedipine in rats.
    Yoshisue K; Nagayama S; Shindo T; Kawaguchi Y
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1166-75. PubMed ID: 11356943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice.
    Yasuda M; Kato S; Yamanaka N; Iimori M; Utsumi D; Kitahara Y; Iwata K; Matsuno K; Amagase K; Yabe-Nishimura C; Takeuchi K
    Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1133-42. PubMed ID: 22403796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R; Tanabe K; Inoue H; Toge T
    Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tolerance of human body to simultaneous infusion of 5-fluorouracil and calcium folinate].
    Chen JY; Peng XZ; Chen LT; Lin Q; Zhang H
    Ai Zheng; 2003 Apr; 22(4):418-20. PubMed ID: 12704003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermittent FLDP: 24-h infusion of 5-FU on days 1, 3 and 5 combined with low-dose cisplatin on days 1-5 for gastric cancer, and its pharmacologic and kinetic rationale.
    Terashima M; Irinoda T; Kawamura H; Takagane A; Abe K; Oyama K; Fujiwara H; Saito K; Gotoh M; Shirasaka T
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):240-6. PubMed ID: 12655443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine.
    Correale P; Del Vecchio MT; Di Genova G; Savellini GG; La Placa M; Terrosi C; Vestri M; Urso R; Lemonnier F; Aquino A; Bonmassar E; Giorgi G; Francini G; Cusi MG
    J Natl Cancer Inst; 2005 Oct; 97(19):1437-45. PubMed ID: 16204693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.
    Okuda H; Ogura K; Kato A; Takubo H; Watabe T
    J Pharmacol Exp Ther; 1998 Nov; 287(2):791-9. PubMed ID: 9808711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
    Saif MW; von Borstel R
    Cancer Chemother Pharmacol; 2006 Jul; 58(1):136-42. PubMed ID: 16187114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationships between p53-dependent apoptosis, inhibition of proliferation, and 5-fluorouracil-induced histopathology in murine intestinal epithelia.
    Pritchard DM; Potten CS; Hickman JA
    Cancer Res; 1998 Dec; 58(23):5453-65. PubMed ID: 9850079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of proliferating cell nuclear antigen in severely damaged small intestinal mucosa due to high-dose 5-FU exposure].
    Luo YQ; Wu CT; Wen Y; Liao KX; Zhang JH
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1860-2. PubMed ID: 18159003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of genetic and nongenetic factors for fluorouracil treatment-related severe toxicity: a prospective clinical trial by the German 5-FU Toxicity Study Group.
    Schwab M; Zanger UM; Marx C; Schaeffeler E; Klein K; Dippon J; Kerb R; Blievernicht J; Fischer J; Hofmann U; Bokemeyer C; Eichelbaum M;
    J Clin Oncol; 2008 May; 26(13):2131-8. PubMed ID: 18299612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of conagenin on thrombocytopenia induced by antitumor agents in mice.
    Kawatsu M; Yamashita T; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1994 Oct; 47(10):1123-9. PubMed ID: 7961162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NTP technical report on toxicity studies of urethane in drinking water and urethane in 5% ethanol administered to F344/N rats and B6C3F1 mice.
    Chan PC
    Toxic Rep Ser; 1996 Mar; (52):1-91, A1-9, B1-9 passim. PubMed ID: 11803705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-treatment with insulin-like growth factor-I partially ameliorates 5-fluorouracil-induced intestinal mucositis in rats.
    Cool JC; Dyer JL; Xian CJ; Butler RN; Geier MS; Howarth GS
    Growth Horm IGF Res; 2005 Feb; 15(1):72-82. PubMed ID: 15701575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell activation by conagenin in mice.
    Kawatsu M; Yamashita T; Osono M; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1993 Nov; 46(11):1687-91. PubMed ID: 8270490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect and toxicity of entrapped polysiloxane 5-Fu polycondensate].
    Fu NW; Zhang LS; Quan LP; Guo R
    Zhonghua Zhong Liu Za Zhi; 1987 Nov; 9(6):415-7. PubMed ID: 3452537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention by chitosan of myelotoxicity, gastrointestinal toxicity and immunocompetent organic toxicity induced by 5-fluorouracil without loss of antitumor activity in mice.
    Kimura Y; Okuda H
    Jpn J Cancer Res; 1999 Jul; 90(7):765-74. PubMed ID: 10470290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.